| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27 | 0 | 0 |
| Total Expenses - EUR | 45 | 33 | 33 | 11 | 11 | 10 | 10 | 529 | 10 | 10 |
| Gross Profit/Loss - EUR | -45 | -33 | -33 | -11 | -11 | -10 | -10 | -502 | -10 | -10 |
| Net Profit/Loss - EUR | -45 | -33 | -33 | -11 | -11 | -10 | -10 | -502 | -10 | -10 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Intermed House Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 312.711 | 309.522 | 304.284 | 298.700 | 292.915 | 287.362 | 280.990 | 281.862 | 281.007 | 279.436 |
| Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders Funds | 312.175 | 308.958 | 303.697 | 298.113 | 292.329 | 286.777 | 280.407 | 280.775 | 279.913 | 278.339 |
| Social Capital | 49 | 49 | 48 | 47 | 46 | 45 | 44 | 45 | 44 | 44 |
| Debts | 1.111 | 1.133 | 1.147 | 1.137 | 1.125 | 1.114 | 1.099 | 1.087 | 1.094 | 1.098 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Intermed House Srl